Norwegian Cruise Line (NCLH) reported Q2 earnings of $0.51 per share and revenues of $2.52 billion for the quarter ended June 2025, both missing Zacks Consensus Estimates by -1.92% and 1.55% respectively, despite year-over-year growth from $0.4 EPS and $2.37 billion revenue. This performance contributes to NCLH shares underperforming the S&P 500 year-to-date, declining 9.1% against the index's 8.2% gain, while its industry ranks in the bottom 29% of Zacks industries. The sustainability of the stock's immediate price movement and future outlook will largely depend on management's commentary during the earnings call, with current consensus estimates for the next quarter at $1.17 EPS on $3.02 billion revenue.
Norwegian Cruise Line (NCLH) reported second-quarter results that fell short of market expectations, creating a mixed signal for investors. The company posted earnings of $0.51 per share and revenue of $2.52 billion, missing consensus estimates by 1.92% and 1.55%, respectively. This marks the second consecutive quarter NCLH has missed EPS forecasts, following a more significant -22.22% surprise in the prior quarter. Despite these misses, the firm demonstrated year-over-year growth, with EPS up from $0.40 and revenue increasing from $2.37 billion a year ago. This performance disconnect has contributed to the stock's significant underperformance, with shares declining 9.1% year-to-date against the S&P 500's 8.2% gain. Compounding these concerns, the broader Leisure and Recreation Services industry is ranked in the bottom 29% of over 250 Zacks industries, suggesting sector-wide headwinds. The current Zacks Rank #3 (Hold) for NCLH indicates an expectation of in-line market performance, but the stock's near-term trajectory will be heavily dependent on management's guidance during the earnings call and subsequent analyst estimate revisions.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment